Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma
Laboratory Medicine · 2026
DOI: 10.1093/labmed/lmaf075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2026. Verfasst von Amina A Abd El Fattah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Biochemistry Division, Faculty of Science, Mansoura University, Mansoura 35516, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Osteopontin, Liver Neoplasms, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study aimed to investigate the utility of vascular endothelial growth factor (VEGF) and osteopontin (OPN) as predictive biomarkers in hepatocellular carcinoma patients (HCC) and cirrhosis and identifying its potential diagnosis of HCC.
Methods
We used enzyme-linked immunosorbent assay to estimate serum levels of OPN and VEGF in 82 Egyptian patients hospitalized for liver transplantation at our Gastrointestinal Surgery Center and 40 nondisease control (NDC) individuals.
Results
Overall, OPN, VEGF, and ɑ-fetoprotein (AFP) higher levels were statistically significantly higher in patients with HCC than in patients with cirrhosis and in the NDC group as well as between patients with cirrhosis and in the NDC group (P < 0.001); OPN and VEGF exhibited statistically significant predictive ability for tumor progression. The diagnostic performance of OPN, VEGF, and AFP using receiver operating characteristic curve analysis showed that OPN demonstrated diagnostic accuracy (85.36%), with an area under the curve of 0.927, supporting its clinical applicability; VEGF showed moderate diagnostic accuracy (65.90%), with an area under the curve of 0.715.
Discussion
Overall, OPN and VEGF displayed substantial predictive ability for tumor progression and can be employed as early markers of the onset of HCC. Osteopontin can effectively distinguish between HCC and cirrhosis and can be used in conjunction with AFP to provide the most accurate diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Biochemistry Division, Faculty of Science, Mansoura University, Mansoura 35516, Egypt.
- Gastrointestinal Surgery Centre, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
- Department of Immunology, Mansoura Children Hospital, Mansoura University, Mansoura 35516, Egypt.
Zitieren
APA
Abd El Fattah, A. A., Youssef, M. M., Abdel-Wahab, M., Gouida, M. S., & El-Emshaty, H. M. (2026). Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma. Laboratory Medicine. https://doi.org/10.1093/labmed/lmaf075
Vancouver
Abd El Fattah AA, Youssef MM, Abdel-Wahab M, Gouida MS, El-Emshaty HM. Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma. Laboratory Medicine. 2026. doi:10.1093/labmed/lmaf075
BibTeX
@article{AbdElFattah2026,
author = {Abd El Fattah, Amina A and Youssef, Magdy M and Abdel-Wahab, Mohamed and Gouida, Mona S and El-Emshaty, Hoda M},
title = {Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma},
journal = {Laboratory Medicine},
year = {2026},
doi = {10.1093/labmed/lmaf075}
}
EUVIMED